Evidence map›Paper›PMID 35039242›Full record

ArticleEuropean urology focus2022

The Prevalence of Nocturnal Polyuria in the United States: Results from the Epidemiology of Nocturnal Polyuria Study.

Jeffrey P Weiss, J L H Ruud Bosch, Christopher R Chapple, Elizabeth D Bacci, Jason C Simeone, Matt T Rosenberg, Elizabeth R Mueller, Fredrik L Andersson, Kristian Juul, Bilal Chughtai and 1 more

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in European urology focus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04125186 (Epidemiology and Burden of Nocturia Due to Nocturnal Polyuria in the United States), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04125186 completednot on this map

Epidemiology and Burden of Nocturia Due to Nocturnal Polyuria in the United States: The EpiNP Study

TypeobservationalSponsorFerring PharmaceuticalsRan2019 to 2020Enrolled10,190ConditionsNocturnal PolyuriaArmsBaseline EpiNP survey, Bladder diary, Testing of EpiNP baseline survey, bladder diary and a qualitative interview, No other intervention
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Jeffrey P WeissSUNY Downstate Health Sciences University, Brooklyn, NY, USA.
J L H Ruud BoschFranciscus G&V Hospital, Rotterdam, The Netherlands.
Christopher R ChappleUniversity of Sheffield, Sheffield, UK.
Elizabeth D BacciEvidera, Seattle, WA, USA.
Jason C SimeoneFormerly with Evidera, Waltham, MA, USA.
Matt T RosenbergMid Michigan Health Center, Jackson, MI, USA.
Elizabeth R MuellerLoyola University Medical Center, Maywood, IL, USA.
Fredrik L AnderssonFerring Pharmaceuticals, Copenhagen, Denmark.
Kristian JuulFerring Pharmaceuticals, Copenhagen, Denmark.
Bilal ChughtaiWeill Cornell Medicine, New York, NY, USA.
Karin S CoyneEvidera, Bethesda, MD, USA. Electronic address: Karin.Coyne@evidera.com.
Ithaka Harbors · USFerring Pharmaceuticals (Denmark) · DKCornell University · USLoyola University Medical Center · USSint Franciscus Gasthuis · NLSUNY Downstate Health Sciences University · USUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of nocturnal polyuria (NP), which is passing large volumes of urine during the main sleep period, has been investigated primarily in middle-aged to older men. There is thus a gap in the NP evidence base for women and for younger individuals.

objectiveTo estimate the prevalence of nocturia due to NP in the USA. DESIGN, SETTING, AND

participantsThis large epidemiologic study used a US population-representative sample of men and women aged ≥30 yr to assess the prevalence of NP (NCT04125186). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Consenting participants completed an online survey (Lower Urinary Tract Symptoms Tool and comorbidities). All who reported two or more voids per night and 100 random respondents each reporting no or one void per night were asked to complete a 3-d bladder diary. Two NP definitions were used: nocturnal urine production >90 ml/h (NUP90) and Nocturnal Polyuria Index >0.33 (NPI33). Crude and population-adjusted prevalence results were calculated from completed diaries for the following subgroups by sex and age: idiopathic NP; NP with overactive bladder (NP-OAB) or bladder outlet obstruction (NP-BOO; men only); NP associated with other comorbidities; and no NP (did not meet the NPI33 or NUP90 definition). RESULTS AND LIMITATIONS: Among the 10,190 respondents who completed the survey, the mean age was 54.4 yr (range 30-95); 3,339 reported two or more nocturnal voids and 1,763 completed the 3-d diary (response rate 49.3%). The adjusted overall NP prevalence was 31.5% among men and 38.5% among women using the NPI33 definition, and 23.8% among men and 18.1% among women using NUP90. The adjusted idiopathic NP prevalence was lower among men (NPI33: 5.2%; NUP90: 1.4%) than among women (NPI33: 9.8%; NUP90: 4.0%). The prevalence of idiopathic NP decreased with age as NP associated with other possible causes increased with age in men (most common, BOO) and women (most common, OAB).

conclusionsThis is the first population-based study of NP prevalence to include men, women, and young adults. NP is common; a multifactorial etiology should be considered, particularly as age increases. PATIENT SUMMARY: In this population-based US study, we examined the frequency of nighttime urination among men and women aged ≥30 y and older. We found that nighttime urination is common among men and women. Many conditions can lead to increased nighttime urination as people age.

Indexed as

Lower Urinary Tract SymptomsNocturiaAgedFemaleHumansMaleMiddle AgedPolyuriaPrevalenceUnited StatesUrinationEpidemiologyNocturiaNocturnal polyuria

Identifiers

PMID35039242
OpenAlexW4205658773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.